Cyclodextrins and Their Derivatives: A Basis for New Drug Formulations
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 29914
Special Issue Editors
Interests: hypertension; structure elucidation; nuclear magnetic resonance; spectroscopy; NMR spectroscopy; medicinal and pharmaceutical chemistry; molecular modeling; Raman spectroscopy; DSC; NMR structure elucidation
Special Issues, Collections and Topics in MDPI journals
Interests: drug development; theranostics; diagnostics; therapeutics; plant extracts
Special Issues, Collections and Topics in MDPI journals
Interests: drug–protein binding; drug-cyclodextrins interaction, characterization and effect on drug solubility/dissolution/absorption; development and in vitro–in vivo evaluation of novel dosage forms with optimized absorption (GI/nasal/pulmonary); PK/PD studies and dosage individualization
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
As Guest Editors, we would like to announce a Special Issue entitled “Cyclodextrins and their Derivatives. A Basis for New Drug Formulations”. This Special Issue will collect communications, research articles, and high-quality review papers in the research fields relating to cyclodextrins, cyclodextrin derivatives, and drug–cyclodextrin interactions, for application in drug formulation developments. We kindly encourage research groups working in various areas of pharmaceutical technology, biopharmaceutics, medicinal and pharmaceutical chemistry, and chemical biology to make contributions to this Special Issue involving, but not restricted to: trends in novel cyclodextrin/cyclodextrin derivatives development, drug–cyclodextrin interactions, applications for novel drug formulations, repurposing of known drug entities through the development of new dosage forms for different routes of administration, pulmonary, nasal, transdermal, etc., and evaluation in vitro/ex vivo/in vivo. In addition, researchers are encouraged to submit articles or reviews that include existing and new methodologies suitable for studying drug–cyclodextrin interactions. The molecular nature of these interactions is critical for rational drug design. Reviews outlining the advantages and disadvantages of existing formulations are also welcome. Furthermore, research articles and review papers on cyclodextrin design, development, and characterization for application in drug design are also suitable for this Special Issue.
Prof. Dr. Thomas Mavromoustakos
Prof. Dr. Andreas G. Tzakos
Prof. Dr. Georgia N. Valsami
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cyclodextrin design/development/characterization
- drug–cyclodextrin interactions/formulations
- analytical methodologies for drug–cyclodextrin interactions/structure elucidation
- in vitro/ex vivo/in vivo evaluation
- other routes of drug administration (nasal, pulmonary, transdermal, etc.)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.